Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company's development stage product candidates...
Q1 2026
May 14, 2026
FY 2025
Feb 23, 2026
Q4 2025
Q3 2025
Nov 10, 2025
Q2 2025
Aug 7, 2025